That is still lower than the average weight loss achieved in clinical trials of Eli Lilly's rival obesity therapy Zepbound (tirzepatide), a dual GLP-1/GIP agonist, which helped patients shed 20.9% of their weight at the same 72-week time point in its pivotal trial
Practitioners who master this multidisciplinary approach are positioned to generate $300,000 to $500,000 or more in annual revenue while delivering measurable, life-changing outcomes for their patients
Retatrutide side effects appear to be dose-related, with higher doses generally linked to more frequent or noticeable symptoms
: Tirzepatide Tirzepatide CAS 2023788-19-2 -20 95-98% mg Product NameTirzepatide Synonyms CAS No.2023788-19-2 Catalog No.GT-L007 DescriptionTirzepatide () (GIP) -1 (GLP-1) 2 TirzepatidesemaglutidelysPEGTirzepatide (GIP) -1 (GLP-1) 2 Purity (HPLC) 95.0% Single impurity2% Peptide content75.0% Amino Acid Composition15% Bacterial Endotoxins50EU/mg Vacuum-packed with aluminum foil bag or transparent bag
The chronic inflammatory skin disorder is strongly associated with overweight and obesity, affecting up to 50% of patients
drugmaker announced plans to invest $3 billion over the next decade to expand its supply chain and build local manufacturing capacity for its experimental obesity and diabetes drug Orforglipron